These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16281886)

  • 21. Estimation of number of subjects required for comparison of drug versus control in adaptive designs.
    Hu FF; Hu JH
    Ann Acad Med Singap; 2000 Sep; 29(5):565-9. PubMed ID: 11126689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response-adaptive randomization for clinical trials with continuous outcomes.
    Zhang L; Rosenberger WF
    Biometrics; 2006 Jun; 62(2):562-9. PubMed ID: 16918921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptive designs for sequential experiments.
    Lin ZY; Zhang LX
    J Zhejiang Univ Sci; 2003; 4(2):214-20. PubMed ID: 12659237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher order response adaptive urn designs for clinical trials with highly successful treatments.
    Ivanova A; Hoberman S
    J R Stat Soc Ser C Appl Stat; 2015 Jan; 64(1):175-189. PubMed ID: 25641991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaches to expanding the two-arm biased coin randomization to unequal allocation while preserving the unconditional allocation ratio.
    Kuznetsova OM; Johnson VP
    Stat Med; 2017 Jul; 36(16):2483-2498. PubMed ID: 28337776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomization procedures in orthopaedic trials.
    Randelli P; Arrigoni P; Lubowitz JH; Cabitza P; Denti M
    Arthroscopy; 2008 Jul; 24(7):834-8. PubMed ID: 18589273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptive treatment allocation for comparative clinical studies with recurrent events data.
    Gao J; Su PF; Hu F; Cheung SH
    Biometrics; 2020 Mar; 76(1):183-196. PubMed ID: 31282997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choosing a covariate-adaptive randomization procedure in practice.
    Zagoraiou M
    J Biopharm Stat; 2017; 27(5):845-857. PubMed ID: 28166466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response adaptive randomization design for a two-stage study with binary response.
    Shan G
    J Biopharm Stat; 2023 Sep; 33(5):575-585. PubMed ID: 36735855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response-adaptive treatment allocation for clinical studies with recurrent event and terminal event data.
    Su PF
    Stat Med; 2022 Jan; 41(2):258-275. PubMed ID: 34693543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Balance and randomness in sequential clinical trials: the dominant biased coin design.
    Antognini AB; Zagoraiou M
    Pharm Stat; 2014; 13(2):119-27. PubMed ID: 24443205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exact group-sequential designs for clinical trials with randomized play-the-winner allocation.
    Stallard N; Rosenberger WF
    Stat Med; 2002 Feb; 21(4):467-80. PubMed ID: 11836730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of the urn randomization in clinical trials.
    Wei LJ; Lachin JM
    Control Clin Trials; 1988 Dec; 9(4):345-64. PubMed ID: 3203525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementing unequal randomization in clinical trials with heterogeneous treatment costs.
    Sverdlov O; Ryeznik Y
    Stat Med; 2019 Jul; 38(16):2905-2927. PubMed ID: 31049999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating response-adaptive randomization procedures for recurrent events and terminal event data using a composite endpoint.
    Mau YL; Su PF
    Pharm Stat; 2022 Nov; 21(6):1167-1184. PubMed ID: 35853695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doubly adaptive biased coin design to improve Bayesian clinical trials with time-to-event endpoints.
    Cao W; Zhu H; Wang L; Zhang L; Yu J
    Stat Med; 2024 Apr; 43(9):1743-1758. PubMed ID: 38387866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New algorithm for treatment allocation reduced selection bias and loss of power in small trials.
    Hofmeijer J; Anema PC; van der Tweel I
    J Clin Epidemiol; 2008 Feb; 61(2):119-24. PubMed ID: 18177784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Start-up designs for response-adaptive randomization procedures with sequential estimation.
    Haines LM; Sadiq H
    Stat Med; 2015 Sep; 34(21):2958-70. PubMed ID: 25944171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials.
    Thall P; Fox P; Wathen J
    Ann Oncol; 2015 Aug; 26(8):1621-8. PubMed ID: 25979922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.